Pioneering mRNA technology - Moderna
Learn how we’re changing the world of medicine. Discover career opportunities, our product pipeline, and browse media resources. Meet Moderna.
Moderna Files for FDA Authorization of Its Updated COVID-19 …
Jun 22, 2023 · To learn more, visit www.modernatx.com. AUTHORIZED USE IN THE U.S. Emergency uses of the vaccine have not been approved or licensed by the FDA, but have been authorized by the FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19).
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine
Sep 11, 2023 · To learn more, visit www.modernatx.com. AUTHORIZED USE IN THE U.S. Emergency uses of the Moderna COVID-19 Vaccine (2023-2024 Formula) have not been approved or licensed by the FDA, but have been authorized by the FDA, under an Emergency Use Authorization (EUA) for use in individuals 6 months through 11 years of age.
mRNA medicines we are currently developing - Moderna
Track the development of Moderna’s mRNA medicines. From preclinical development to commercial phase.
Our Story - Moderna
We’re making biotech history. Since 2010, we have worked to build the industry's leading mRNA technology platform. Learn more about Moderna’s history.
Moderna COVID-19 Vaccine (2024-2025 Formula) | Moderna
In addition, you can report side effects to ModernaTX, Inc. at 1-866-MODERNA (1-866-663-3762). Please see the Moderna COVID-19 Vaccine (2024-2025 Formula) Fact Sheet for Recipients and Caregivers for more information.
Moderna Achieves Positive Interim Results from Phase 3 Trial of …
Mar 26, 2024 · For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn. Spikevax ® is a registered trademark of Moderna.
Moderna Advances Multiple Vaccine Programs to Late-Stage …
Mar 27, 2024 · For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn. INDICATION (U.S.) SPIKEVAX (COVID-19 Vaccine, mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome ...
Investor Relations Overview - Moderna
[email protected]. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription.
Moderna Expands the Field of mRNA Medicine with Positive …
Sep 13, 2023 · To learn more, visit www.modernatx.com. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: the potential for Moderna to launch up to 15 products in the next five years, and advancement of new ...